Andexanet Alfa FDA Committee Meeting Recap
Nick Peters recaps and discusses the FDA hearing regarding andexanet alfa and their supplemental Biologics Licensing Application.
Pharmacy to Dose: The Critical Care Podcast
November 28, 202454m 2s
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Andexanet Alfa FDA Committee Meeting Recap
03:08 – Purpose/Background
13:30 – Thromboembolism
25:45 – Efficacy/Patient-centered outcomes
34:55 – Discussion questions
Advisory Committee Meeting Link: https://www.youtube.com/live/xztpe5-d9eY
PharmacyToDose.Com
@PharmacyToDose
Learn more about your ad choices. Visit megaphone.fm/adchoices